These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31481418)
61. Ovarian and cervical cancer patient derived xenografts: The past, present, and future. Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736 [TBL] [Abstract][Full Text] [Related]
62. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification. Oh DY; Jung K; Song JY; Kim S; Shin S; Kwon YJ; Oh E; Park WY; Song SY; Choi YL BMC Cancer; 2017 Aug; 17(1):535. PubMed ID: 28806950 [TBL] [Abstract][Full Text] [Related]
63. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways. Wang H; Lu J; Tang J; Chen S; He K; Jiang X; Jiang W; Teng L BMC Cancer; 2017 Mar; 17(1):191. PubMed ID: 28292264 [TBL] [Abstract][Full Text] [Related]
64. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis. Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290 [TBL] [Abstract][Full Text] [Related]
65. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence. Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319 [TBL] [Abstract][Full Text] [Related]
66. Patient-derived xenograft (PDX) tumors increase growth rate with time. Pearson AT; Finkel KA; Warner KA; Nör F; Tice D; Martins MD; Jackson TL; Nör JE Oncotarget; 2016 Feb; 7(7):7993-8005. PubMed ID: 26783960 [TBL] [Abstract][Full Text] [Related]
67. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine. Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792 [TBL] [Abstract][Full Text] [Related]
68. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer. Chen Z; Huang W; Tian T; Zang W; Wang J; Liu Z; Li Z; Lai Y; Jiang Z; Gao J; Shen L J Hematol Oncol; 2018 Feb; 11(1):20. PubMed ID: 29433585 [TBL] [Abstract][Full Text] [Related]
69. Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice. Martínez-Sabadell A; Ovejero Romero P; Arribas J; Arenas EJ STAR Protoc; 2022 Dec; 3(4):101712. PubMed ID: 36317178 [TBL] [Abstract][Full Text] [Related]
70. A novel patient-derived xenograft model for claudin-low triple-negative breast cancer. Matossian MD; Burks HE; Bowles AC; Elliott S; Hoang VT; Sabol RA; Pashos NC; O'Donnell B; Miller KS; Wahba BM; Bunnell BA; Moroz K; Zea AH; Jones SD; Ochoa AC; Al-Khami AA; Hossain F; Riker AI; Rhodes LV; Martin EC; Miele L; Burow ME; Collins-Burow BM Breast Cancer Res Treat; 2018 Jun; 169(2):381-390. PubMed ID: 29392581 [TBL] [Abstract][Full Text] [Related]
73. Integrated analysis of transcriptome in cancer patient-derived xenografts. Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608 [TBL] [Abstract][Full Text] [Related]
74. Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts. Cornillie J; Wozniak A; Van Renterghem B; Van Winkel N; Wellens J; Gebreyohannes YK; Debiec-Rychter M; Sciot R; Hompes D; Schöffski P BMC Cancer; 2019 Jul; 19(1):724. PubMed ID: 31331295 [TBL] [Abstract][Full Text] [Related]
75. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice. Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555 [TBL] [Abstract][Full Text] [Related]
76. Optimizing the design of population-based patient-derived tumor xenograft studies to better predict clinical response. Floc'h N; Guerriero ML; Ramos-Montoya A; Davies BR; Cairns J; Karp NA Dis Model Mech; 2018 Oct; 11(11):. PubMed ID: 30254068 [TBL] [Abstract][Full Text] [Related]
77. Expanding the concept of patient-derived xenografts cohorts in head and neck cancer: current and future perspectives. Zhang ZY; Sun SY Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Dec; 39(6):617-623. PubMed ID: 34859620 [TBL] [Abstract][Full Text] [Related]
78. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors. Bondarenko G; Ugolkov A; Rohan S; Kulesza P; Dubrovskyi O; Gursel D; Mathews J; O'Halloran TV; Wei JJ; Mazar AP Neoplasia; 2015 Sep; 17(9):735-741. PubMed ID: 26476081 [TBL] [Abstract][Full Text] [Related]
79. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. Matossian MD; Burks HE; Elliott S; Hoang VT; Bowles AC; Sabol RA; Wahba B; Anbalagan M; Rowan B; Abazeed ME; Bunnell BA; Moroz K; Miele L; Rhodes LV; Jones SD; Martin EC; Collins-Burow BM; Burow ME BMC Cancer; 2019 Mar; 19(1):205. PubMed ID: 30845999 [TBL] [Abstract][Full Text] [Related]
80. Noninvasive Detection of HER2 Expression in Gastric Cancer by Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]